1887

Abstract

Mixed infections occur in the natural environment, and also result from the use of mixed live vaccines. Some recipients of the trivalent oral poliovirus vaccine develop vaccine-associated paralytic poliomyelitis (VAPP). Numerous serotypes and recombinant genotypes of vaccine-derived polioviruses may be found in stool samples from such cases. To investigate the relationship between the multiplication of various genotypes at the primary replication site in the gut and the infection outcome in the central nervous system (CNS), the viruses excreted on consecutive days by two patients with VAPP were compared with the viruses isolated from the CNS. The genotypes from stools were numerous and varied with time in both cases, suggesting a multiplication of the viruses in multiple foci in the gut. Where the CNS isolated virus clearly corresponded to one of the many viruses detected in stool, this virus was unexpectedly less neurovirulent than others isolated from stool. To assess the mechanism by which viruses with different degrees of neurovirulence are selected in the CNS, transgenic mice sensitive to poliovirus infection were inoculated extraneurally with mixtures of two phenotypically different viruses at different neuropathogenic doses. The virus(es) inducing neurological disease was then isolated from the CNS. At less than 100% input neuropathogenic dose of both inoculated viruses, individual mice were affected stochastically by the virus variants from the mixture. Extrapolated to humans, this selection pattern might explain the occurrence of CNS infections with less neurotropic viruses derived from an extraneural pool containing also highly neurotropic viruses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-8-1819
1997-08-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/8/9266975.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-8-1819&mimeType=html&fmt=ahah

References

  1. Balanant J., Guillot S., Candrea A., Delpeyroux F., Crainic R. 1991; The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virologyr 184:645–654
    [Google Scholar]
  2. Bodian D., Horstmann D. H. 1965; Polioviruses. In Viral and Rickettsial Infections of Man pp 430–473 Horsfall F. L., Tamm I. Edited by Philadelphia: Lippincott;
    [Google Scholar]
  3. Bodian D., Howe H. A. 1955; Emerging concept of poliomyelitis infection. Science 122:105–108
    [Google Scholar]
  4. Cheynier R., Henrichwark S., Hadida F., Pelletier E., Oksenhendler E., Autran B., Wain-Hobson S. 1994; HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78: 373–387
    [Google Scholar]
  5. Christodoulou C., Colbère-Garapin F., Macadam A., Taffs L. F., Marsden S., Minor P. D., Horaud F. 1990; Mapping of mutations associated with monkey neurovirulence of Sabin 1 poliovirus revertants selected at high temperature. Journal of Virology 64:4922–4929
    [Google Scholar]
  6. Chumakov K. M., Powers L. B., Noonan K. E., Roninson I. B., Levenbook I. S. 1991; Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proceedings of the National Academy of Sciences USA: 88199–203
    [Google Scholar]
  7. Clarke D. K., Duarte E. A., Elena S. F., Moya A., Domingo E., Holland J. 1994; The Red Queen reigns in the kingdom of RNA viruses. Proceedings of the National Academy of Sciences USA: 914821–4824
    [Google Scholar]
  8. de la Torre J. C., Holland J. J. 1990; RNA virus quasispecies populations can suppress vastly superior mutant progeny. Journal of Virology 64:6278–6281
    [Google Scholar]
  9. Fichot O., Girard M. 1990; An improved method for sequencing of RNA templates. Nucleic Acids Research 18:6162
    [Google Scholar]
  10. Furione M., Guillot S., Otelea D., Balanant J., Candrea A., Crainic R. 1993; Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196: 199–208
    [Google Scholar]
  11. Georgescu M. -M., Delpeyroux F., Tardy-Panit M., Balanant J., Combiescu M., AubertCombiescu A., Guillot S., Crainic R. 1994; .High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. Journal of Virology 68: 8089–8101
    [Google Scholar]
  12. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S. 1982; Rapid evolution of RNA genomes. Science 215:1577–1585
    [Google Scholar]
  13. Holland J. J., de la Torre J. C., Clarke D. K., Duarte E. 1991; Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. Journal of Virology 65:2960–2967
    [Google Scholar]
  14. Katz J. M., Webster R. G. 1988; Antig enic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual. Virology 165:446–456
    [Google Scholar]
  15. Koike S., Taya C., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto A. 1991; Transgenic mice susceptible to poliovirus. Proceedings of the National Academy of Sciences USA: 88951–955
    [Google Scholar]
  16. Macadam A. J., Pollard S. R., Ferguson G., Skuce R., Wood D., Almond J. W., Minor P. D. 1993; Genetic basis of attenuation of the Sabin type-2 vaccine strain of poliovirus in primates. Virology 192:18–26
    [Google Scholar]
  17. Minor P. D. 1992; The molecular biology of poliovaccines. Journal of General Virology 73:3065–3077
    [Google Scholar]
  18. Minor P. D., John A., Ferguson M., Icenogle J. P. 1986; Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion of primary vaccinee. Journal of General Virology 67:693–706
    [Google Scholar]
  19. Morrison L. A., Fields B. N. 1991; Viral pathogenesis of central nervous infection. Seminars in the Neurosciences 3:83–91
    [Google Scholar]
  20. Nkowane B. M., Wassilak S. G. F., Orenstein W. A. 1987; Vaccine- associated paralytic poliomyelitis. United States 1973 through 1984. Journal of the American Medical Association 257: 1335–1340
    [Google Scholar]
  21. Pelletier E., Saurin W., Cheynier R., Letvin N. L., Wain-Hobson S. 1995; The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology 208:644–652
    [Google Scholar]
  22. Reed L. J., Muench M. 1938; A simple method for estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  23. Ren R. B., Racaniello V. R. 1992; Poliovirus spreads from muscle to the central nervous system by neural pathways. Journal of Infectious Diseases 166:747–752
    [Google Scholar]
  24. Ren R., Moss E. G., Racaniello V. R. 1991; Identification of two determinants that attenuate vaccine-related type 2 poliovirus. Journal of Virology 65:1377–1382
    [Google Scholar]
  25. Sabin A. B. 1956; Pathog enesis of poliomyelitis. Science 123:1151–1157
    [Google Scholar]
  26. Sabin A. B., Boulger L. R. 1973; History of Sabin attenuated poliovirus oral live vaccine strains. Journal of Biological Standardization 1:115–118
    [Google Scholar]
  27. Sala M., Zambruno G., Vartanian J. -P., Marconi A., Bertazzoni U., Wain-Hobson S. 1994; Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection. Journal of Virology 68:5280–5283
    [Google Scholar]
  28. Toyoda H., Kohara M., Kataoka Y., Suganuma T., Omata T., Imura N., Nomoto A. 1984; Complete nucleotide sequences of all three poliovirus serotype genomes. implication for genetic relationship, gene function and antigenic determinants. Journal of Molecular Biology 174:561–585
    [Google Scholar]
  29. Wimmer E., Hellen C. U. T., Cao X. M. 1993; Genetics of poliovirus. Annual Review of Genetics 27:353–436
    [Google Scholar]
  30. Wyatt H. V. 1990; Incubation of poliomyelitis as calculated from the time of entry into the central nervous system via the peripheral nerve pathways. Reviews of Infectious Diseases 12:547–556
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-8-1819
Loading
/content/journal/jgv/10.1099/0022-1317-78-8-1819
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error